A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

NCT06547840 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Ovarian Cancer
Platinum-resistant Ovarian Cancer
Triple Negative Breast Cancer (TNBC)
Triple -Negative Breast Cancer
Endometrial Cancer
Advanced Endometrial Cancer

Interventions

DRUG: MOv18 IgE

Sponsor

Epsilogen Ltd